Platelet receptors for adenine nucleotides and thromboxane A2.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Seminars in Thrombosis and Hemostasis

• Publication date

  2004-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1055/S-2004-833476PMID 15354262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet-active drugs : the relationships among dose, effectiveness, and side effects.

  2004cited by this paper
• Inhibition of localized thrombosis in P2Y1‐deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist

  2003cited by this paper
• Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets.

  2003cited by this paper
• Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype.

  2003cited by this paper
• Platelet purinergic receptors.

  2003cited by this paper
• ADP receptors--targets for developing antithrombotic agents.

  2003cited by this paper
• P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries.

  2003cited by this paper
• BM-573, a Dual Thromboxane Synthase Inhibitor and Thromboxane Receptor Antagonist, Prevents Pig Myocardial Infarction Induced by Coronary Thrombosis

  2003cited by this paper
• P2X1-mediated ERK2 Activation Amplifies the Collagen-induced Platelet Secretion by Enhancing Myosin Light Chain Kinase Activation*

  2003cited by this paper
• Differential Involvement of the P2Y1 and P2Y12 Receptors in Platelet Procoagulant Activity

  2003cited by this paper
• A Role of the Fast ATP-gated P2X1 Cation Channel in Thrombosis of Small Arteries In Vivo

  2003cited by this paper
• Lineage‐specific overexpression of the P2Y1 receptor induces platelet hyper‐reactivity in transgenic mice

  2003cited by this paper
• In Vivo Blockade of Platelet ADP Receptor P2Y12 Reduces Embolus and Thrombus Formation but Not Thrombus Stability

  2003cited by this paper
• Role of ADP Receptor P2Y12 in Platelet Adhesion and Thrombus Formation in Flowing Blood

  2002cited by this paper
• Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease

  2002cited by this paper
• Effects of Enhanced P2X1 Receptor Ca2+ Influx on Functional Responses in Human Platelets

  2002cited by this paper
• P2X(1)-mediated activation of extracellular signal-regulated kinase 2 contributes to platelet secretion and aggregation induced by collagen.

  2002cited by this paper
• A study of P2X1 receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors

  2002cited by this paper
• Functional Significance of Adenosine 5′-Diphosphate Receptor (P2Y12) in Platelet Activation Initiated by Binding of von Willebrand Factor to Platelet GP Ib&agr; Induced by Conditions of High Shear Rate

  2002cited by this paper
• Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.

  2002cited by this paper
• Function of prostanoid receptors: studies on knockout mice.

  2002cited by this paper
• Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.

  2002cited by this paper
• Costimulation of Gi- and G12/G13-mediated signaling pathways induces integrin alpha IIbbeta 3 activation in platelets.

  2002cited by this paper
• Coordinated Signaling through Both G12/13 and Gi Pathways Is Sufficient to Activate GPIIb/IIIa in Human Platelets*

  2002cited by this paper
• Novel platelet inhibitors.

  2001cited by this paper
• Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha,beta-methylene ATP.

  2001cited by this paper
• Identification of the platelet ADP receptor targeted by antithrombotic drugs

  2001cited by this paper
• Resistance to thromboembolism in PI3Kgamma-deficient mice.

  2001cited by this paper
• Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow.

  2001cited by this paper
• The ATP-Gated P2X1 Ion Channel Acts as a Positive Regulator of Platelet Responses to Collagen

  2001cited by this paper
• Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist.

  2001cited by this paper
• Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor.

  2001cited by this paper
• Effects of P2Y 1 and P2Y 12 receptor antagonists on platelet aggregation induced by different agonists in human whole blood

  2001cited by this paper
• P2y(12), a new platelet ADP receptor, target of clopidogrel.

  2001cited by this paper
• Impaired activation of murine platelets lacking G alpha(i2).

  2001cited by this paper
• Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.

  2001cited by this paper
• Potentiation of Thromboxane A2-induced Platelet Secretion by Gi Signaling through the Phosphoinositide-3 Kinase Pathway

  2001cited by this paper
• The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanism.

  2001cited by this paper
• ADP Is the Cognate Ligand for the Orphan G Protein-coupled Receptor SP1999*

  2001cited by this paper
• Signalling events underlying platelet aggregation induced by the glycoprotein VI agonist convulxin.

  2001cited by this paper
• Activation of the platelet collagen receptor integrin alpha(2)beta(1): its mechanism and participation in the physiological functions of platelets.

  2000cited by this paper
• ADP is not an agonist at P2X1 receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets

  2000cited by this paper
• The P2Y1 receptor mediates ADP-induced p38 kinase-activating factor generation in human platelets.

  2000cited by this paper
• ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq.

  2000cited by this paper
• The central role of the P2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity

  2000cited by this paper
• ADP receptors and clinical bleeding disorders.

  1999cited by this paper
• Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors.

  1999cited by this paper
• Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice

  1999cited by this paper
• Role of Intracellular Signaling Events in ADP-induced Platelet Aggregation

  1999cited by this paper
• Phosphorylation of the Thromboxane Receptor α, the Predominant Isoform Expressed in Human Platelets*

  1999cited by this paper
• Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice.

  1999cited by this paper
• No requirement of P2X1 purinoceptors for platelet aggregation.

  1999cited by this paper
• A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.

  1998cited by this paper
• P2X1 Purinoceptor in Human Platelets

  1998cited by this paper
• Expression and tissue distribution of the mRNAs encoding the human thromboxane A2 receptor (TP) alpha and beta isoforms.

  1998cited by this paper
• Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.

  1998cited by this paper
• Molecular Basis for ADP-induced Platelet Activation

  1998cited by this paper
• Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation.

  1998cited by this paper
• Molecular Basis for ADP-induced Platelet Activation

  1998cited by this paper
• Presence of P2X1 Purinoceptors in Human Platelets and Megakaryoblastic Cell Lines

  1997cited by this paper
• The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha.

  1997cited by this paper
• Defective platelet activation in G alpha(q)-deficient mice.

  1997cited by this paper
• Activation of Receptor-operated Cation Channels via P Not P Purinoceptors in Human Platelets (*)

  1996cited by this paper
• Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor.

  1996cited by this paper
• Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation.

  1996cited by this paper
• Cloning and chromosomal localization of the human P2Y1 purinoceptor.

  1996cited by this paper
• The human platelet ADP receptor activates Gi2 proteins.

  1995cited by this paper
• G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets.

  1994cited by this paper
• Role of platelets in thrombosis and hemostasis.

  1994cited by this paper
• Identification of Gq as one of the G-proteins which copurify with human platelet thromboxane A2/prostaglandin H2 receptors.

  1993cited by this paper
• ADP Receptor Antagonists and Converting Enzyme Systems Reduce Platelet Deposition onto Collagen

  1992cited by this paper
• Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.

  1992cited by this paper
• The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family.

  1991cited by this paper
• Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists.

  1991cited by this paper
• The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.

  1990cited by this paper
• Thromboxane A2: its generation and role in platelet activation.

  1989cited by this paper
• Purification of the thromboxane A2/prostaglandin H2 receptor from human blood platelets.

  1989cited by this paper
• Prostaglandins and thromboxanes.

  1978cited by this paper

• Quantitative liquid chromatography-tandem mass spectrometric analysis of 11dH-TXB2 and creatinine in urine

  2025cites this paper
• Resistance training reduces platelet activation in hypertensive women: the role of purinergic signaling

  2023cites this paper
• Regulation of platelet proaggregant activity in cyclooxygenase inhibition in patients with nephrolithiasis

  2023cites this paper
• Glycoprotein IIb/IIIa inhibitors for the neurointerventionalist

  2021cites this paper
• Urinary 11‐dehydrothromboxane B2 concentrations in 20 dogs with primary immune‐mediated hemolytic anemia

  2021cites this paper
• The Roles of GRKs in Hemostasis and Thrombosis

  2020cites this paper
• Platelet Glycoprotein IIb/IIIa Receptor Inhibitor Tirofiban in Acute Ischemic Stroke

  2019cites this paper
• Platelets in chronic liver disease, from bench to bedside

  2019cites this paper
• GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets.

  2019cites this paper
• Platelet retention in inflamed glomeruli occurs via selective prolongation of interactions with immune cells.

  2019cites this paper
• Protein Kinase Cɛ in the Platelet and Hippocampal Tissue as a Diagnostic Biological Marker in Alzheimer Disease

  2019cites this paper
• Interaction between platelets and endothelium: from pathophysiology to new therapeutic options.

  2018cites this paper
• Comparative study of platelet indices in coronary artery diseases

  2018cites this paper
• The role of thromboxane A2 in complement activation-related pseudoallergy

  2017cites this paper
• Intraoperative Eptifibatide Administration During Urgent Arterial Bypass in Neurosurgery.

  2017cites this paper
• cAMP signaling reverses platelet spreading via inhibition of RhoA

  2016cites this paper
• Evaluation of the effect of angiotensin converting enzyme inhibitors and angiotensin receptors blockers on aspirin antiplatelet effect.

  2016cites this paper
• THE ROLE OF CYCLOOXYGENASE-1 (COX-1) AND CYCLOOXYGENASE-2 (COX-2) IN A VENOUS THROMBOSIS MOUSE MODEL

  2016cites this paper
• Blood Coagulation Studies on modified Surfaces using Quartz Crystal Microbalance

  2015cites this paper
• Platelets and Their Interactions with Other Immune Cells.

  2015cites this paper
• Evaluation of Three Whole Blood Platelet Function Tests in Healthy Cats and Effects of Acetylsalicylic Acid and Clopidogrel

  2015cites this paper
• The association of thromboxane A2 receptor with lipid rafts is a determinant for platelet functional responses

  2014cites this paper
• Possible role of Eptifibatide drip in-patient with aneurysmal subarachnoid hemorrhage in vasospasm prevention.

  2014cites this paper
• The platelet: life on the razor's edge between hemorrhage and thrombosis

  2014cites this paper
• Platelets: Still a Therapeutical Target for Haemostatic Disorders

  2014cites this paper
• Regulation of Platelet Activity in a Changing Redox Environment

  2014cites this paper
• Pharmacological inhibition of platelet reactivity. Clinical and pharmacodynamic effects.

  2013cites this paper
• Efficacy of Curcumin in Reducing Risk of Cardiovascular Disease in High Fat Diet-Fed Rats

  2013cites this paper
• Platelet Cd Markers By Flow Cytometry In Normal Individuals And In Patients With Untreated Type 2 Diabetes Mellitus

  2013cites this paper
• Platelet Structure, Function, and Disorders

  2012cites this paper
• Metabolomic investigation of the anti-platelet aggregation activity of ginsenoside Rk₁ reveals attenuated 12-HETE production.

  2012cites this paper
• Protein Kinase C Isoform &egr; Negatively Regulates ADP-Induced Calcium Mobilization and Thromboxane Generation in Platelets

  2012cites this paper
• Thromboxane Generation in Platelets Negatively Regulates ADP-Induced Calcium Mobilization and ε Protein Kinase C Isoform

  2012cites this paper
• Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin

  2012cites this paper
• Glycoprotein IIb/IIIa Antagonists in Acute Ischaemic Stroke

  2012cites this paper
• Alcoholism and traumatic subarachnoid hemorrhage: Further study on changes of TXA-2 / TXA2R and death mechanisms

  2011cites this paper
• Role of Platelets in Primary Hemostasis and Atherothrombosis

  2011cites this paper
• Safety and feasibility of intraarterial eptifibatide as a revascularization tool in acute ischemic stroke.

  2011cites this paper
• G12/13 Signaling Pathways Substitute for Integrin αIIbβ3-Signaling for Thromboxane Generation in Platelets

  2011cites this paper
• Aspirin: Pharmacology and Clinical Applications

  2011cites this paper
• Functional analyses of Arabidopsis apyrases 3 through 7

  2011cites this paper
• Antithrombotic drug therapy in cardiovascular disease

  2010cites this paper
• Platelet-Vessel Wall Interactions in Hemostasis and Thrombosis

  2010cites this paper
• PI 3-Kinase p110b Regulation of Platelet Integrin a IIb b 3

  2010cites this paper
• Platelets in Arterial Thrombosis

  2010cites this paper
• PI 3-Kinase p110β regulation of platelet integrin α(IIb)β3.

  2010cites this paper
• [From platelet functions to therapy].

  2010cites this paper
• Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrel.

  2009cites this paper
• Theoretical calculation and experimental study of influence of oxygen vacancy on the electronic structure and hemocompatibility of rutile TiO2

  2009cites this paper
• Platelet P2Y12 receptor inhibition by thienopyridines: status and future

  2009cites this paper
• Augmentation of U46619 induced human platelet aggregation by aspirin

  2009cites this paper
• Functional characterization of a salivary apyrase from the sand fly, Phlebotomus duboscqi, a vector of Leishmania major.

  2009influential citation
• Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets.

  2008cites this paper
• Characteristics, diagnosis, and treatment of inherited platelet disorders in mammals.

  2008cites this paper
• Reciprocal regulation of platelet responses to P2Y and thromboxane receptor activation

  2008cites this paper
• Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions.

  2008cites this paper
• APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice

  2008influential citation
• Can we use adenosine diphosphate (ADP) to study "aspirin resistance"? The Janus faces of ADP-triggered platelet aggregation.

  2008cites this paper
• The tetraspanin CD9 localizes to platelet-platelet contacts and regulates thrombus stability

  2008cites this paper
• Glycoprotein receptor mediated regulation of platelet morphology

  2007cites this paper
• Improved blood compatibility of rapamycin-eluting stent by incorporating curcumin.

  2007cites this paper
• Paxillin family members function as Csk-binding proteins that regulate Lyn activity in human and murine platelets.

  2007cites this paper
• MONOMERIC AND DIMERIC DISINTEGRINS: PLATELET ACTIVE AGENTS FROM VIPER VENOM

  2007cites this paper
• Platelet-neutrophil-interactions: linking hemostasis and inflammation.

  2007cites this paper
• In vitro studies of platelet adhesion, activation, and protein adsorption on curcumin-eluting biodegradable stent materials.

  2007cites this paper
• Arf6 plays an early role in platelet activation by collagen and convulxin.

  2006influential citation
• High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

  2006cites this paper
• Gastrointestinal Tumors: Metastasis and Tetraspanins

  2006cites this paper
• Influence on platelet aggregation of i.v. parecoxib and acetaminophen in healthy volunteers.

  2006cites this paper
• The calcium activated nucleotidases: A diverse family of soluble and membrane associated nucleotide hydrolyzing enzymes

  2006cites this paper
• Plaquetas: ainda um alvo terapêutico

  2006cites this paper
• Gastroprotective effects of oral nucleotide administration

  2005cites this paper
• Measurement of adhesion of human platelets in plasma to protein surfaces in microplates.

  2005cites this paper
• administration Gastroprotective effects of oral nucleotide

  2005cites this paper